The ascendancy of Viagra and its effect on the pharmaceutical landscape presents a intricate question for shareholders. While the early sales statistics were impressive, the intellectual property has lapsed, leading to https://flynncwyx308470.blogtov.com/22078750/the-blue-pill-and-the-pharmaceutical-industry-a-speculative-opportunity